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Alternative life cycles of Epichloe and Neotyphodium species in host grasses. The 
Neotyphodium (formerly Acremonium) endophytes have only the asexual/vertical 
transmission life cycle. Thus, unlike Epichloe species, the Neotyphodium species cannot 
transmit contagiously; that is, they cannot transmit from an infected plant of one maternal 
lineage to an uninfected plant of a different maternal lineage. However, the Neotyphodr'um 
species and some Epichloe species transmit vertically at extremely high frequency, such 
that 98%-] 00% of seeds produced on an endophyte-containing mother plant also contain 
endophyte and, upon germination, give rise to endophyte-containing plants. Also, there 
are standard methods whereby seedlings or other plant material that lacks endophyte 
can be inoculated with mycelium of wild type or transformed endophyte to give rise 
to endophyte-containing plants; and such plants will pass on the endophyte in the nonnal 
fashions shown here depending on whether the endophyte is compatible with that host 
grass and what is (are) its normal transmission mode(s) [Latch et al., [07 Annals of 
Applied Biology 17 (1985)][Tsai et al., 22 Current Genet 399 (l992)]. 
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ENDOPHYTE ERGOT ALKALOID 
SYNTHETIC COMPOUNDS, COMPOUNDS 
WHICH ENCODE THEREFOR AND 
RELATED METHODS 
This application claims priority to US. Provisional 
Patent Application Serial No. 60/125,490, Which Was ?led 
on Mar. 22, 1999. 
The present invention Was funded in part by USDA NRI 
grant 95-37303-1678; the US. Government may have cer 
tain rights in this invention. 
FIELD OF THE INVENTION 
The present invention relates to sequences that encode 
dimethylallyl-diphosphate:L-tryptophan dimethylallyltrans 
ferase (“DmaW” or “dimethylallyltryptophan synthase”), an 
enZyme present in some grass endophytes, and that catalyZes 
the formation of 4- y,y-dimethylallyltryptophan. This 
enZyme activity is the ?rst committed step in the production 
of ergot alkaloids, including those With clavine and ergoline 
ring structures. Such alkaloids include clavines, lysergic 
acid, lysergic acid amides, and ergopeptines. The sequences 
encode a DmaW from fungi that are symbionts of commer 
cially signi?cant grasses. 
BACKGROUND OF THE INVENTION 
Certain fungal species eXist as symbiotic and integral 
parts of grasses and are passed from generation to generation 
of plants, but many are not passed from plant to plant eXcept 
by transmitting in seeds of maternal plant lineages. Repre 
sentatives of these fungi are the Neotyphoa'ium species 
(“Neotyphodium” and sometimes “Acremonium”, for 
eXample, N. coenophialum) and Epichloe species (eg E. 
festucae and E. typhina), Which are symbionts and integral 
parts of many grass cultivars. These fungi, termed 
“endophytes”, are seed-transmissible at extremely high effi 
ciency. Their symbioses With host grasses are characteriZed 
by mutual bene?ts to the hosts and symbionts. Bene?ts to 
the grass hosts include protection from insects and 
vertebrates, and resistance to Water stress (drought). Anti 
insect activities are mainly due to pyrrolopyraZine and 
pyrroliZidine alkaloids produced by the endophytes. Anti 
vertebrate activities are mainly due to indole alkaloids, 
including the ergot alkaloids (clavines, lysergic acid and its 
derivatives, and ergopeptines). 
Tall fescue is groWn on over 14 million hectares as an 
important forage, turf and conservation grass; most of the 
tall fescue groWn in the US. contains ergot-alkaloid 
producing endophytes. The anti vertebrate activity of the 
ergot alkaloids, Which manifests as “tall fescue toXicosis” in 
cattle and other livestock, causes losses estimated at more 
than $600 million per year. 
In 1992, Gebler and Poulter puri?ed the DmaW enZyme 
from Claviceps sp. ATCC 26245 to a single protein band 
observable by SDS-PAGE electrophoresis, and fragmented 
the protein With CNBr. Gebler et al., 114 Journal of the 
American Chemical Society 7354 (1992). The three resulting 
fragments Were puri?ed and their N-termini sequenced. In 
research by one of the inventors of the present invention, 
there Was disclosed a sequence of a dmaW gene (herein 
dmaW) from C. fusiformis AT CC 26245 organism from 
Which the sequence Was identi?ed Was mis-named C. pur 
purea by the supplier to the ATCC, and Was actually C. 
fusiformis.) Tsai et al., 216 Biochem & Biophys Res Comm 
119 (1995). The C. fusiformis sequence from that research is 
58% identical to the present sequences at the DNA level. 
10 
15 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
2 
More recently, a C. purpurea dmaW sequence Was disclosed 
in TudZynski et al., 261 Molec Gen Genet 133 (1999), and 
is 62% identical at the DNA level to the present sequence. 
Citation of the above documents is not intended as an 
admission that any of the foregoing is pertinent prior art. For 
eXample, in some instances above, the publication Was less 
than one year before the ?ling date of this patent application. 
All statements as to the date or representation as to the 
contents of these documents is based on subjective charac 
teriZation of information available to the applicant at the 
time of ?ling, and does not constitute an admission as to the 
accuracy of the dates or contents of these documents. 
SUMMARY OF THE INVENTION 
It is therefore an object of the present invention to provide 
sequences useful to engineer ergot alkaloid-de?cient 
symbionts, thus ergot-alkaloid-de?cient plants. 
It is a further object to provide methods to engineer ergot 
alkaloid-de?cient endophytes. 
It is yet another object to provide ergot alkaloid-de?cient 
seeds. 
It is yet another object to provide plants With ergot 
alkaloid-de?cient endophytes. 
It is also an object of the invention to provide materials 
such as vectors for engineering ergot alkaloid-de?cient 
endophytes. 
It is also an object of the invention to provide enZymes 
useful in ergot alkaloid synthesis. 
Also, it is an object to use the present nucleic acid 
compounds to determine the potential or lack of potential of 
symbiont strains to produce ergot alkaloids. 
Other objects Will be apparent from the present disclo 
sure. 
De?nitions: 
For the purposes of the present application, the folloWing 
terms have the folloWing meanings. All other terms have the 
meaning as speci?cally recogniZed in the art. 
“Allelic variant” is meant to refer to a full length gene or 
partial sequence of a full length gene that occurs at essen 
tially the same locus (or loci) as the referent sequence, but 
Which, due to natural variations caused by, for eXample, 
mutation or recombination, has a similar but not identical 
sequence. Allelic variants typically encode proteins having 
similar activity to that of the protein encoded by the gene to 
Which they are being compared. Allelic variants can also 
comprise alterations in the 5‘ or 3‘ untranslated regions of the 
gene (e.g., in regulatory control regions). 
“Fragment” is meant to refer to any subset of the referent 
nucleic acid sequence. 
“Knockout construct” means a DNA sequence Which has 
been altered via any knoWn means, for eXample, deletion, 
insertion, point mutation or rearrangement, so as to alter or 
eliminate the function of the naturally-occurring sequence 
product, but not so as to alter the ability of the DNA 
sequence to recombine With the naturally-occurring 
sequence. 
“Knockout mutants” are cells, embryos, fungi or plants in 
Which a naturally-occurring dmaW sequence has been 
replaced through genetic engineering With a knockout 
construct, so as to result in a ergot alkaloid-de?cient 
phenotype, especially a dimethylallyl-diphosphate:L 
tryptophan dimethylallyltransferase- de?cient phenotype. 
“Proteins” means any compounds Which comprise amino 
acids, including peptides, polypeptides, fusion proteins, etc. 
Moreover, for the purposes of the present invention, the 
term “a” or “an” entity refers to one or more of that entity; 
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for example, “a protein” or “a nucleic acid molecule” refers 
to one or more of those compounds or at least one com 
pound. As such, the terms “a” (or “an”), “one or more” and 
“at least one” can be used interchangeably herein. It is also 
to be noted that the terms “comprising”, “including”, and 
“having” can be used interchangeably. Furthermore, a com 
pound “selected from the group consisting of” refers to one 
or more of the compounds in the list that folloWs, including 
mixtures (i.e., combinations) of tWo or more of the com 
pounds. According to the present invention, an isolated, or 
biologically pure, protein or nucleic acid molecule is a 
compound that has been removed from its natural milieu. As 
such, “isolated” and “biologically pure” do not necessarily 
re?ect the extent to Which the compound has been puri?ed. 
An isolated compound of the present invention can be 
obtained from its natural source, can be produced using 
molecular biology techniques or can be produced by chemi 
cal synthesis. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 schematically depicts the ?rst step of the herein 
described indirect gene replacement. 
FIG. 2 schematically depicts the second step of the 
herein-described indirect gene replacement. 
FIG. 3 schematically depicts the herein-described 
homologous gene replacement. 
FIG. 4 schematically depicts the alternative life cycles of 
Epichloe and Neotyphodium species in host grasses. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention provides, inter alia, isolated nucleic 
acid molecule encoding a DmaW sequence, Wherein said 
nucleic acid molecule comprises a nucleic acid sequence 
selected from the group consisting of: 
(a) a nucleic acid sequence Which has more than 63% 
identity to a sequence selected from the group consist 
ing of SEQ ID NO 1 and SEQ ID NO 3, and Wherein 
said identity can be determined using the DNAsis 
computer program and default parameters; 
(b) a nucleic acid molecule selected from the group 
consisting of: a nucleic acid molecule Which encodes a 
DmaW amino acid sequence selected from the group 
consisting of: SEQ ID NO 2; SEQ ID NO 4; a protein 
encoded by an allelic variant of SEQ ID NO 1; and a 
protein encoded by an allelic variant of SEQ ID NO 3. 
Allelic variants, fragments (including a portion of a 
molecule) and homologues are, by de?nition of “nucleic 
acid molecule”, included Within this and other embodiments. 
Included Within the scope of the present invention, With 
particular regard to the nucleic acids above, are allelic 
variants, degenerate sequences and homologues. Allelic 
variants are expected to be found in nature. The present 
invention also includes variants due to laboratory 
manipulation, such as, but not limited to, variants produced 
during polymerase chain reaction ampli?cation or site 
directed mutagenesis. It is also Well knoWn that there is a 
substantial amount of redundancy in the various codons 
Which code for speci?c amino acids. Therefore, this inven 
tion is also directed to those nucleic acid sequences Which 
contain alternative codons Which code for the eventual 
translation of the identical amino acid. Also included Within 
the scope of this invention are mutations either in the nucleic 
acid sequence or the translated protein Which do not sub 
stantially alter the ultimate physical properties of the 
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expressed protein. For example, substitution of valine for 
leucine, arginine for lysine, or asparagine for glutamine may 
not cause a change in functionality of the polypeptide. 
Lastly, a nucleic acid sequence homologous to the exempli 
?ed nucleic acid molecules (or allelic variants or degener 
ates thereof) can have approximately 85%, preferably 
approximately 90%, and most preferably approximately 
95% sequence identity With a nucleic acid molecule in the 
sequence listing. 
Stringent hybridiZation conditions are determined based 
on de?ned physical properties of the gene to Which the 
nucleic acid molecule is being hybridiZed, and can be 
de?ned mathematically. Stringent hybridiZation conditions 
are those experimental parameters that alloW an individual 
skilled in the art to identify signi?cant similarities betWeen 
heterologous nucleic acid molecules. These conditions are 
Well knoWn to those skilled in the art. See, for example, 
Sambrook, et al., 1989, Molecular Cloning: A Laboratory 
Manual, Cold Spring Harbor Labs Press, and Meinkoth, et 
al., 1984, Anal. Biochem. 138, 267-284. 
It is knoWn in the art that there are commercially available 
computer programs for determining the degree of similarity 
betWeen tWo nucleic acid sequences. These computer pro 
grams include various knoWn methods to determine the 
percentage identity and the number and length of gaps 
betWeen hybrid nucleic acid molecules. Preferred methods 
to determine the percent identity among amino acid 
sequences and also among nucleic acid sequences include 
analysis using one or more of the commercially available 
computer programs designed to compare and analyZe 
nucleic acid or amino acid sequences. These computer 
programs include, but are not limited to, GCGTM (available 
from Genetics Computer Group, Madison, Wis), DNAsisTM 
(available from Hitachi SoftWare, San Bruno, Calif.) and 
MacVectorTM (available from the Eastman Kodak Company, 
NeW Haven, Conn.). A preferred method to determine per 
cent identity among amino acid sequences and also among 
nucleic acid sequences includes using the Compare function 
by maximum matching Within the program DNAsis Version 
2.1 using default parameters. 
In one embodiment of the present invention, a preferred 
dmaW nucleic acid molecule includes an isolated nucleic 
acid molecule Which is at least about 50 nucleotides, or at 
least about 150 nucleotides, and Which hybridiZes under 
conditions Which preferably alloW about 25% base pair 
mismatch, more preferably under conditions Which alloW 
about 20% base pair mismatch, more preferably under 
conditions Which alloW about 15% base pair mismatch, 
more preferably under conditions Which alloW about 10% 
base pair mismatch and even more preferably under condi 
tions Which alloW about 5% base pair mismatch With a 
nucleic acid molecule selected from the group consisting of 
SEQ ID NO 1 and SEQ ID NO 3. 
Another embodiment of the present invention includes a 
nucleic acid molecule comprising at least about 150 base 
pairs, Wherein the nucleic acid molecule hybridiZes, in a 
solution comprising 1X SSC and 0% formamide, at a 
temperature of about 56° C., to a nucleic acid sequence 
selected from the group consisting of: SEQ ID NO 1 and 
SEQ ID NO 3. Also preferred are fragments of any of such 
nucleic acid molecules. 
Additional preferred dmaW nucleic acid molecules of the 
present invention include an isolated nucleic acid molecule 
Which is at least about 50 nucleotides, or at least about 150 
nucleotides, comprising a nucleic acid sequence that is 
preferably at least about 65% identical, more preferably 
about 70% identical, more preferably about 75% identical, 
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5 
more preferably about 80% identical, more preferably about 
85% identical, more preferably about 90% identical and 
even more preferably about 95% identical to a nucleic acid 
sequence selected from the group consisting of SEQ ID NO 
1 and SEQ ID NO 3. Also preferred are fragments of any of 
such nucleic acid molecules. Percent identity may be deter 
mined using the Compare function by maximum matching 
Within the program DNAsis Version 2.1 using default 
parameters. 
Vectors Which comprise the above molecules are Within 
the scope of the present invention, as are endophytes and 
other fungi transformed With the above sequences as are 
plants having endophytes transformed With the above 
sequences. Vectors may be obtained from various commer 
cial sources, including Clontech Laboratories, Inc. (Palo 
Alto, Calif), Stratagene (La Jolla, Calif), Invitrogen 
(Carlsbad, Calif.), NeW England Biolabs (Beverly, Mass.) 
and Promega (Madison, Wis). 
Preferred vectors are those Which are capable of transfer 
ring the molecules disclosed herein into fungal cells. A 
vector Which provided for either an early or late promoter in 
conjunction With the present sequences Would be useful in 
certain circumstances. For instance, the folloWing promoters 
Would be useful in early expression of the present 
sequences: 
glyceraldehyde-3-phosphate dehydrogenase gene pro 
moter [Jungehiilsing et al., 25 Current Genetics 101 
(1994)]. 
trpC promoter [Yelton et al., 82 Proceedings of the 
National Academy of Sciences of the United States of 
America 834 (1985)]. 
beta-tubulin gene promoter [Tsai et al., 22 Current Genet 
ics 399 (1992)]. 
These are fungal promoters that are knoWn to Work in 
endophytes or (for the glyceraldehyde-3-phosphate dehy 
drogenase gene promoter) the related fungus Claviceps 
purpurea. 
In order to then constitutively express the sequences 
described above, the construct optionally contains, for 
example, a beta-tubulin promoter according to the procee 
dures in Tsai et al., 22 Current Genetics 399 (1992). 
Moreover, the most commercially signi?cant use of the 
present invention is in the construction of “knockout 
mutants” using the above sequences, or knoWn sequences, 
for design and construction of DmaW-de?cient mutants. In 
other Words, the present invention is informative to those 
skilled in the art as to their usefulness in making the 
naturally-occurring sequence inactive. For example, the 
above sequences can be mutated by any means, i.e., deletion, 
insertion, point mutation, rearrangement, etc, so long as the 
mutated version or sequences nearby in replicatable DNA of 
the fungus (e.g. chromosome) retains the ability to recom 
bine. The mutated version of the sequence is then introduced 
into cells of a preferred line via routine methods (i.e. 
biolistic processes, electroporation, treatment of Wall-less 
cells With vector, Agrobacterium-mediated transformation, 
etc.). DmaW-de?cient mutants of the preferred line Would 
then be selected and propagated. These “knockout” mutant 
embryos, seeds and plants are Within the scope of the present 
invention, as are the knockout constructs, i.e. sequences and 
vectors. 
In particular, sequences near the active site of enZyme 
function, and the site itself, Would be preferred targets. 
Moreover, sequences Which are conserved among related 
organisms are also preferred targets. It is contemplated that 
a modi?cation of the present invention such that the start 
codon has been eliminated, or replaced With a stop codon, 
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Would be a useful knockout construct. Moreover, excision of 
the coding region or replacing the coding region With a 
antibiotic (i.e. hygromycin) resistance gene Would be useful. 
FIGS. 1 through 3 describe examples of such manipulations. 
For example, the folloWing seeds, embryos or plants With 
endophyte transformed With knockout constructs are con 
sidered Within the present invention. Particularly preferred 
are: forage, turf and conservation grasses. These include, for 
example, tall fescue (Festuca arundinacea), meadoW fescue 
(Festuca pratensis), and red fescue (Festuca rubra), Which 
are common turf, conservation (to hold soil and reclaim strip 
mines) and forage grasses in the US. and WorldWide. Also 
used for these purposes, are the ryegrasses such as perennial 
ryegrass (Lolium perenne). All these have endophytes and 
most such endophytes produce ergot alkaloids. In particular, 
tall fescues are most preferred. HoWever, any seed, embryo 
or plant Which comprise endophytes Which produce ergot 
alkaloid is Within the scope of the present invention. Of 
course, those in the art recogniZe that any seed, embryo or 
plant With endophyte transformed With knockout constructs 
Which are useful for producing plants for biomass are Within 
the scope of the present invention. 
Transformation of cells With the nucleic acid molecules of 
the present invention can be accomplished according to 
knoWn procedures. The folloWing procedures are Well 
knoWn: electroporation [Tsai et al., 22 Current Genetics 399 
(1992)], treatment of Wall-less fungal cells With vector DNA 
plus CaCl2 and polyethyleneglycol [Yelton et al., 81 Pro 
ceedings of the National Academy of Sciences of the United 
States of America 1470 (1984)], and biolistics [Armaleo et 
al., 17 Current Genetics 97 (1990)]. In addition, fungi have 
been transformed using vector-containing bacterial strains, 
namely Agrobacterium tumefaciens [Gouka et al., 17 Nature 
Biotechnology 598 (1999)]. The transformed cells are also 
Within the scope of this invention. 
The transformed cells may be groWn into a fungal myce 
lium (thallus), Which in turn gives rise to spores. Fungal 
mycelium and spores are propagated inde?nitely. In 
addition, transformed fungal endophyte can be introduced 
into grass plants. The current preferred method to introduce 
the fungus into plant is by inoculation of seedling meristems 
[Latch and Christensen, 107 Annals of Applied Biology 17 
(1985)]. Another knoWn method is inoculation and regen 
eration of plant tissue culture [Johnson et al., 70 Plant 
Disease 380 (1986)]. 
Once introduced into a plant the endophyte Will remain 
inde?nitely and propagate inside all plant propagules includ 
ing tillers, stolons, and seeds (unless procedures are under 
taken to eliminate live fungal mycelium in the grass, for 
example by long storage of seeds at ambient temperature). 
In any grass breeding Where the female plant possesses the 
endophyte the seeds Will almost all possess the identical 
endophyte, and those seeds Will give rise to plants With that 
endophyte [Siegel et al., 74 Phytopathology 932 (1984)]. In 
this Way a grass variety With transformed endophyte can be 
developed, propagated, and planted for forage, pasture, turf, 
revegetation, or soil conservation. 
Therefore, also provided are methods for constructing 
sequences With the ability to knockout the above sequences, 
comprising one of the folloWing techniques: inserting a 
foreign piece of DNA into one of the disclosed sequences; 
deleting a piece of DNA from one of the disclosed 
sequences; or creating a mutation such that the DmaW 
activity is eliminated. 
Also provided are antisense constructs and methods to 
inhibit translation or accumulation of mRNA transcripts of 
the disclosed sequences, so as to either eliminate or reduce 
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the amount of sequence product. The procedures for anti 
sense inhibition for mRNA are described in US. Pat. No. 
5,554,743, Which patent is expressly incorporated by refer 
ence into this application. Alternatively, the present inven 
tion could be used to design riboZymes Which speci?cally 
cleave dmaW mRNA. 
Also provided in the present invention are methods to 
express or overexpress the dmaW sequences described 
herein, and using the DmaW in pharmaceutical processes. 
Ergot alkaloids produced in fungal fermentation or chemi 
cally modi?ed ergot alkaloids from fungal fermentation are 
Well knoWn pharmaceuticals. The dmaW gene can be intro 
duced into an ergot alkaloid-producing fungal strain, for 
example of C. purpurea, thus increasing the copy number 
and potentially the expression of the DmaW protein. Utili 
Zation of a constitutive promoter such as for beta-tubulin 
[Tsai et al., 22 Current Genetics 399 (1992)] may help 
increase expression of the gene and, thus, of the protein. 
Because DmaW catalyZes the rate limiting step of ergot 
alkaloid synthesis in C. purpurea [Lee et al., 177 Archives of 
Biochemistry & Biophysics 84 (1976)], its increased expres 
sion may increase ergot alkaloid production. The loW level 
of sequence identity betWeen dmaW from different genera 
(for example betWeen dmaW sequences of Neotyphodium 
and Claviceps) Will reduce the problem knoWn as quenching 
or cosuppression Which limits production of gene products 
in fungi and plants [Cogoni et al., 65 Antonie Van Leeu 
Wenhoek International Journal of Microbiology 205 (1994)]. 
Overexpression can be as skill of the art, in particular, 
according to the procedures described in US. Pat. No. 
5,477,001. 
Also provided in the present invention are methods to 
identify Neotyphodium or Acremonium or Epichloe fungi 
that lack dmaW and, therefore, are unlikely to produce ergot 
alkaloids. The cloned Neotyphodium genes can be used for 
standard Southern blot hybridiZation, by anyone skilled in 
the art, to screen these related fungi for the presence of 
homologous genes. In addition, degenerate primers can be 
used for polymerase chain reaction under conditions 
described to amplify segments of dmaW from fungi in 
family Clavicipitaceae or from Neotyphodium or Acremo 
nium species. The ampli?ed segments can be analyZed by 
gel electrophoresis and sequence analysis by anyone skilled 
in the art. Fungi that lack DmaW can then be introduced into 
grass plants and thereby incorporated into breeding lines as 
described above. 
Transformation of plant endophytes With these sequences 
Would be according to knoWn procedures as described 
above. Plants can be groWn according to knoWn procedures. 
Lastly, the present sequences are useful to identify related 
sequences, such as those from Balansia, Balansiopsis, 
Echinodothis, Atkinsonella, Myriogenospora, 
Neotyphodium, and Parepichloe, or natural or induced 
mutants. For example, screening could be by Southern blot 
hybridiZation analysis of genomic DNA or by polymerase 
chain reaction using DNA oligonucleotide primers targeted 
to dmaW or the locus that contains it. 
The present invention also provides isolated proteins 
encoded by a dmaW sequence, Wherein said proteins com 
prise an amino acid sequence selected from the group 
consisting of: 
(a) an amino acid sequence Which has more than 68% 
identity to an amino acid sequence selected from the 
group consisting of SEQ ID NO 2 and SEQ ID NO 4 
and Wherein said identity can be determined using the 
DNAsis computer program and default parameters; and 
(b) an amino acid sequence Which is encoded by a nucleic 
acid sequence of claim 1. 
10 
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There are also provided recombinant cells comprising the 
nucleic acid molecules and/or proteins herein described. 
Proteins Which Would result from expression of the 
nucleic acid molecules herein disclosed are preferred, With 
the proteins Which Would result from expression of the 
exempli?ed nucleic acid molecules being most preferred. It 
is understood that proteins Which Would result from expres 
sion of allelic variants of the exempli?ed sequences, as Well 
as proteins Which Would result from the expression of 
nucleic acid molecules Which hybridiZe under stringent 
hybridiZation conditions to the nucleic acid molecules exem 
pli?ed are Within the scope of the present invention as Well. 
Lastly, an amino acid sequence substantially homologous to 
a referent dmaW-encoded protein Will have at least 85% 
sequence identity, preferably 90%, and most preferably 95% 
sequence identity With the amino acid sequence of a referent 
dmaW-encoded protein or a peptide thereof. For example, an 
amino acid sequence is substantially homologous to dmaW 
encoded protein if, When aligned With dmaW-encoded 
protein, at least 85% of its amino acid residues are the same. 
SEQ ID NO 2 and SEQ ID NO 4 are the most preferred 
proteins. 
DmaW homologs can be the result of natural allelic 
variation or natural mutation. DmaW homologs of the 
present invention can also be produced using techniques 
knoWn in the art including, but not limited to, direct modi 
?cations to the protein or modi?cations to the gene encoding 
the protein using, for example, classic or recombinant 
nucleic acid techniques to effect random or targeted 
mutagenesis. 
EXAMPLE 
Example 1 
Obtaining dmaW sequence from N. coenophialum 
The folloWing degenerate primers Were used to amplify 
genomic DNA fragments from N. coenophialum by poly 
merase chain reaction (PCR). A (+) means they correspond 
in sequence to a portion of mRNA, thus read 5‘—3‘ on the 
gene, and a (—) indicates they are reverse complements of a 
portion of the mRNA and read 3‘—5‘ on the gene: thus, each 
PCR involved a combination of a (+) and a (—) primer. 
dmaWdeg(+)1: GAR CAR MGN YTN TGG TGG CA 
dmaWdeg(+)2: GGN AT H TTY AAR AAR CAY AT 
dmaWdeg(-)3: AR NGT CCA NAR RTC YTC CAT 
dmaWdeg(-)4: TA NAC YTG NGG YTC NGG CAT 
N=A,G,C or T; Y=C or T; R=A or G; M=A or C; H=A, 
T or C. 
Four PCR reactions Were performed to amplify fragments 
from each fungus, using four different primer combinations, 
dmaWdeg(+)1 and dmaWdeg(-)3, dmaWdeg(+)1 and 
dmaWdeg(-)4, dmaWdeg(+)2 and dmaWdeg(-)3, 
dmaWdeg(+)2 and dmaWdeg(-)4. Each 50 microL reaction 
mixture contained 200ng fungal genomic DNA template, 
200 microM each deoxyribonucleotide triphosphate (dATP, 
dGTP, dTTP and dCTP), 25 mM each primer, 1 X PCR 
buffer (Perkin-Elmer), and 2.5 units Taq DNA polymerase 
(AmpliTaq Gold from Perkin-Elmer). Reactions Were held 
at 93 ° C. for 9 min and 95° C. for 3 min, then subjected to 
35 cycles of the folloWing pro?le: 94° C. for 45 s, 53° C. for 
45 s, 72° C. for 80 s in a Perkin-Elmer model 2400 Thermal 
Cycler. After completing these temperature cycles the reac 
tions Were incubated 5 min at 72° C., then analyZed by 
agarose gel electrophoresis. 
The resulting ampli?ed genomic fragments Were cloned 
and used as probes of a cosmid library (and thus obtained 
US 6,335,188 B1 
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SEQ ID NO 1 of N. coenophialum dmaW), or the sequences 
Were used as a basis for neW primers for anchored single 
primer PCR (and thus obtained SEQ ID NO 3 of N. 
coenophialum dmaW). 
10 
alkaloid synthetic properties of the endophyte/grass sym 
biosis Will be determined by standard chemical methods. 
Example 3 
Clones Were sequenced using PE Biosystems Model 310 5 
Genetic Analyzer. DNA sequence analysis ‘Was ‘carried out Identity Comparisons 
With the DNAs1s (Hitachi) and GCG (University of Wis 
consin Genetics Computer Group, Madison) sequence The GAP program of the Wisconsin Genetics Group GCG 
analysis packages. Alignment of sequences Was done using package Was used to compare the original sequence from 
CLUSTALW according to Thompson et al., 22 Nucl. Acids 10 ATCC 26245 (C. fusiformis) With SEQ ID NO 1 and SEQ 
Res. 4673 (1994). ID NO 3, and likeWise With the C. purpurea ATCC 20102 
dmaW gene (sequenced by the present lab, and identical to 
Example 2 the sequence published by TudZynski et al, cited in 
_ Background). Comparisons both With nucleic acid and With 
Constructlon of knockout mutants 15 amino acid sequences Were made, though for hybridiZation 
Clones Will be constructed containing DNA of each anaiysls 03?, £1136 nillglggalcld ldenllltg?ls lhmpzgtatiie' in 
dmaW locus from Which all or part of the gene has been eacl 621,5; 6 Q _ 6gza‘zlgsségd y _1g1er 1 eleted, r in Which the dmaW has been mutated to a form n 3 233152;: tn EgaSATC 2 0016 zennca Ito t S ,d 
eXpected to be inactive. These clones Will be used in an _ _' f 0d 0 e, d gzrieiggmtino 21,61 1 
transformation experiments as described in Tsai et al, 22 2O fei?eilc; tlttls 121%? zggzgm 152713: 872;‘? tt'l t fot? ??léac 
Genetics 399 (1992). Transformants Will be screened by 200102120 6 an ' 0 O a 0 6 
Southern blot hybridiZation and polymerase chain reaction gene‘ 
to identify those that have had the Wild type gene replaced Although the present invention has been fully described 
by the mutant form. In endophytes With more than one herein, it is to be noted that various changes and modi?ca 
dmaW copy, such as N. coenophialum, the procedure Will be 25 tions are apparent to those skilled in the art. Such changes 
repeated until all active or potentially active copies are and modi?cations are to be understood as included Within 
replaced With inactive forms. The endophyte, so altered, Will the scope of the present invention as de?ned by the 
be introduced into its natural host, and the loss of ergot appended claims. 
SEQUENCE LISTING 
<l60> NUMBER OF SEQ ID NOS: 6 
<210> SEQ ID NO 1 
<2ll> LENGTH: 1347 
<2 12> TYPE: DNA 
<2 13> ORGANISM: Neotyphodium coenophialum 
<400> SEQUENCE: 1 
atggtaatgg caaagacact ccaccaggaa gtttatcata cccttagcga aacatttgac 60 
tttgccaaca atgaccagag gctatggtgg cacagcacgg cgccaatgtt cgaaaagatg 120 
ctccaaactg ctaactatag cattgatgct cagtatcgac atctgggcat ttataagagc 180 
catgtcattc cttttcttgg tgtctatcct acaagaagtg gcgagcggtg gctaagcatt 240 
cttacgagat acggaacccc gtttgagcta agtcttaatt gctcggactc cgtagttcgg 300 
tatacatacg agcctattaa cgccgcaact ggcagtcatc tggatccgtt taacactttc 360 
gctatctggg aggccctgaa aaagcatatt gagtcccagc caggcataga ccttgaatgg 420 
ttttcttact ttaaacaaga gcttacactt gacgcaaacg agtccacgta cctgcactcg 480 
caaaacttgg ttaaggaaca gatcaaaact caaaacaagc tcgctttgga ccttaaaggt 540 
gacaagttcg tactgaagac ctacatctac cccgaattga agtccgtcgc aactggtaaa 600 
tcggtccagg agctcgtgtt tggctccgtc cgcaagctag cgcagaagca caagagtatc 660 
cgtcctgcct ttgaaatgct agaagactat gtccagtctc gcaataaatt ctctaccacg 720 
gatgacagtc acaatactct attatcttca cgccttctct cttgcgacct gataagtcct 780 
accaagtctc gtgtcaagat ctacctcctg gaacgaatgg tctcgttgcc agcgatggaa 840 
gatctttgga cgcttggcgg ccgtcgagaa gatcagtcca ctattgaggg attggagatg 900 
11 
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atccgagaac 
tacttgcccc 
caccataatg 
atggaggtga 
agtaaataca 
tatatccact 
ctccactcct 
gcatgccggc 
Met 
1 
Glu 
Thr 
Asp 
Phe 
65 
Leu 
Ser 
His 
His 
Lys 
145 
Gln 
Asp 
Leu 
Ser 
Glu 
225 
Asp 
Leu 
Met 
Arg 
Val 
Thr 
Ala 
Ala 
50 
Leu 
Thr 
Val 
Leu 
Ile 
130 
Gln 
Asn 
Leu 
Lys 
Val 
210 
Met 
Asp 
Ile 
Val 
Glu 
Met 
Phe 
Pro 
35 
Gln 
Gly 
Arg 
Val 
Asp 
115 
Glu 
Glu 
Leu 
Lys 
Ser 
195 
Arg 
Leu 
Ser 
Ser 
Ser 
275 
Asp 
tttggggtct 
tcggcgccat 
atcccatacc 
ctaatgcact 
aagcctgcct 
cgtacatttc 
ttgaaactgg 
gagatttaac 
PRT 
SEQUENCE: 
Ala 
Asp 
20 
Met 
Tyr 
Val 
Tyr 
Arg 
100 
Pro 
Ser 
Leu 
Val 
Gly 
180 
Val 
Lys 
Glu 
His 
Pro 
260 
Leu 
Gln 
SEQ ID NO 2 
LENGTH: 
TYPE: 
ORGANISM: 
448 
cctcaacatg 
tcccaatgag 
agaaccgcaa 
cacgacattc 
cagggaatct 
cttctcctac 
taaatggcca 
ttgttaa 
tctcctggtt 
caacttccgt 
gtgtacttta 
ttcatgaggc 
ttcccgcatc 
cgaaagaaca 
gtgtttcccg 
Neotyphodium coenophialum 
2 
Lys 
Phe 
Phe 
Arg 
Tyr 
Gly 
85 
Tyr 
Phe 
Gln 
Thr 
Lys 
165 
Asp 
Ala 
Leu 
Asp 
Asn 
245 
Thr 
Pro 
Ser 
Thr 
Ala 
Glu 
His 
Pro 
Thr 
Thr 
Asn 
Pro 
Leu 
150 
Glu 
Lys 
Thr 
Ala 
Tyr 
230 
Thr 
Lys 
Ala 
Thr 
Leu 
Asn 
Lys 
Leu 
55 
Thr 
Pro 
Tyr 
Thr 
Gly 
135 
Asp 
Gln 
Phe 
Gly 
215 
Val 
Leu 
Ser 
Met 
Ile 
His 
Asn 
Met 
40 
Gly 
Arg 
Phe 
Glu 
Phe 
120 
Ile 
Ala 
Ile 
Val 
Lys 
200 
Lys 
Gln 
Leu 
Arg 
Glu 
280 
Glu 
Gln 
Asp 
25 
Leu 
Ile 
Ser 
Glu 
Pro 
105 
Ala 
Asp 
Asn 
Lys 
Leu 
185 
Ser 
His 
Ser 
Ser 
Val 
265 
Asp 
Gly 
Glu 
10 
Gln 
Gln 
Tyr 
Gly 
Leu 
90 
Ile 
Ile 
Leu 
Glu 
Thr 
170 
Lys 
Val 
Lys 
Arg 
Ser 
250 
Lys 
Leu 
Leu 
Val 
Arg 
Thr 
Lys 
Glu 
75 
Ser 
Asn 
Trp 
Glu 
Ser 
155 
Gln 
Thr 
Gln 
Ser 
Asn 
235 
Arg 
Ile 
Trp 
Glu 
tgcgcgccta ccctgagcct 
ccatggccaa 
ctgtgttcgg 
atgaatggag 
atgattacga 
agccatattt 
aaggtctaat 
Tyr 
Leu 
Ala 
Ser 
60 
Arg 
Leu 
Ala 
Glu 
Trp 
140 
Thr 
Asn 
Tyr 
Glu 
Ile 
220 
Lys 
Leu 
Tyr 
Thr 
Met 
His 
Trp 
Asn 
45 
His 
Trp 
Asn 
Ala 
Ala 
125 
Phe 
Tyr 
Lys 
Ile 
Leu 
205 
Arg 
Phe 
Leu 
Leu 
Leu 
285 
Ile 
Thr 
Trp 
30 
Tyr 
Val 
Leu 
Cys 
Thr 
110 
Leu 
Ser 
Leu 
Leu 
Tyr 
190 
Val 
Pro 
Ser 
Ser 
Leu 
270 
Gly 
Arg 
ttacacctta 
catgaatgat 
cgatatggca 
agccctgaat 
aagtgtgtat 
agcatttgac 
Leu Ser 
15 
His Ser 
Ser Ile 
Ile Pro 
Ile Ser 
Ser 
95 
Asp 
Gly Ser 
Lys Lys 
Tyr Phe 
Ser 
160 
His 
Ala 
175 
Leu 
Pro Glu 
Phe Gly 
Ala Phe 
Thr Thr 
240 
Cys 
255 
Asp 
Glu Arg 
Gly Arg 
Glu Leu 
960 
1020 
1080 
1140 
1200 
1260 
1320 
1347 
13 
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290 295 300 
Trp Gly Leu Leu Asn Met Ser Pro Gly Leu Arg Ala Tyr Pro Glu Pro 
305 310 315 320 
Tyr Leu Pro Leu Gly Ala Ile Pro Asn Glu Gln Leu Pro Ser Met Ala 
325 330 335 
Asn Tyr Thr Leu His His Asn Asp Pro Ile Pro Glu Pro Gln Val Tyr 
340 345 350 
Phe Thr Val Phe Gly Met Asn Asp Met Glu Val Thr Asn Ala Leu Thr 
355 360 365 
Thr Phe Phe Met Arg His Glu Trp Ser Asp Met Ala Ser Lys Tyr Lys 
370 375 380 
Ala Cys Leu Arg Glu Ser Phe Pro His His Asp Tyr Glu Ala Leu Asn 
385 390 395 400 
Tyr Ile His Ser Tyr Ile Ser Phe Ser Tyr Arg Lys Asn Lys Pro Tyr 
405 410 415 
Leu Ser Val Tyr Leu His Ser Phe Glu Thr Gly Lys Trp Pro Val Phe 
420 425 430 
Pro Glu Gly Leu Ile Ala Phe Asp Ala Cys Arg Arg Asp Leu Thr Cys 
435 440 445 
<2 10> SEQ ID NO 3 
<211> LENGTH: 1353 
<212> TYPE: DNA 
<213> ORGANISM: Neotyphodium coenophialum 
<400> SEQUENCE: 3 
atggtattgg caaagacact ccaccaggaa gtttatcaaa ccctcagcga aacatttgac 60 
tttgccaaca atgaccagag gctatggtgg cacagcacgg cgccaatgtt ccaaaagata 120 
ctccaaactg ctaactatag catttatgct cagtatcaac atctgagcat ttataaaagc 180 
catatcattc cttttcttgg tgtctatcct acaagaagtg gcgagcggtg gctaagcatt 240 
cttacgagat acggaacccc gtttgagcta agtcttaatt gctctgactc catagttcgg 300 
tatacatacg agcctattaa cgccgcaact ggcagccatc tggatccgtt caacactttc 360 
gctatctggg aggctctaaa aaagcttata gattcccagc caggcataga ccttcaatgg 420 
ttttcctact ttaaacaaga gcttacactt gacgcaaacg agtccacgta cctgcactct 480 
caaaacttgg tcaaggaaca gatcaaaact caaaacaagc tagcgttaga ccttaaaggt 540 
gacaagttcg tactcaagac ctacatctac cccgaattga agtccgtcgc aactggtaaa 600 
tcggtccagg agcttgtgtt tggctccgtc cgcaagctag cgcagaagca taagagtatc 660 
cgtcctgcct ttgaaatgct agaagactat gtccagtctc gcaataaagt ccctaccacg 720 
gatgacagtc acaatactcc attatcttca cgccttctct cttgcgacct ggtgagtcct 780 
accaagtctc gtgtcaagat ctacctcctg gaacgaatgg tctcgttgcc agcgatggaa 840 
gatctttgga cgcttggcgg ccgtcgagaa gatcagtcca ctattgaggg attggagatg 900 
atccgagaac tttggggtct ccttaacatg tctcctggtt tgcgcgccta ccctgagcct 960 
tacttgcccc tcggcgccat tcccaatgag caacttccgt ccatggccaa ttacacctta 1020 
caccataatg atccgatacc agaaccgcaa gtgtacttta ctgtgttcgg catgaatgat 1080 
atggaggtga ctaatgcact cacgaaattc ttcatgaggc atgaatggag cgatatggca 1140 
agtaaataca aagcctgcct tagggaatct ttcccgcatc ataattacga agccctaaat 1200 
tatatccact cgtacatttc cttctcctac cgaaataaca agccatattt aagtgtgtat 1260 
US 6,335,188 B1 
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-oontinued 
ctccactcat ttgaaactgg tgaatggcct gtgtttcccg aaggtctaat agcttttgac 1320 
ggatgccggc gagatttaac ttgttataag tag 1353 
<2l0> SEQ ID NO 4 
<211> LENGTH: 450 
<212> TYPE: PRT 
<213> ORGANISM: Neotyphodium coenophialum 
<400> SEQUENCE: 4 
Met Val Leu Ala Lys Thr Leu His Gln Glu Val Tyr Gln Thr Leu Ser 
1 5 10 15 
Glu Thr Phe Asp Phe Ala Asn Asn Asp Gln Arg Leu Trp Trp His Ser 
20 25 30 
Thr Ala Pro Met Phe Gln Lys Ile Leu Gln Thr Ala Asn Tyr Ser Ile 
35 40 45 
Tyr Ala Gln Tyr Gln His Leu Ser Ile Tyr Lys Ser His Ile Ile Pro 
50 55 6O 
Phe Leu Gly Val Tyr Pro Thr Arg Ser Gly Glu Arg Trp Leu Ser Ile 
65 70 75 80 
Leu Thr Arg Tyr Gly Thr Pro Phe Glu Leu Ser Leu Asn Cys Ser Asp 
85 90 95 
Ser Ile Val Arg Tyr Thr Tyr Glu Pro Ile Asn Ala Ala Thr Gly Ser 
100 105 110 
His Leu Asp Pro Phe Asn Thr Phe Ala Ile Trp Glu Ala Leu Lys Lys 
115 120 125 
Leu Ile Asp Ser Gln Pro Gly Ile Asp Leu Gln Trp Phe Ser Tyr Phe 
130 135 140 
Lys Gln Glu Leu Thr Leu Asp Ala Asn Glu Ser Thr Tyr Leu His Ser 
145 150 155 160 
Gln Asn Leu Val Lys Glu Gln Ile Lys Thr Gln Asn Lys Leu Ala Leu 
165 170 175 
Asp Leu Lys Gly Asp Lys Phe Val Leu Lys Thr Tyr Ile Tyr Pro Glu 
180 185 190 
Leu Lys Ser Val Ala Thr Gly Lys Ser Val Gln Glu Leu Val Phe Gly 
195 200 205 
Ser Val Arg Lys Leu Ala Gln Lys His Lys Ser Ile Arg Pro Ala Phe 
210 215 220 
Glu Met Leu Glu Asp Tyr Val Gln Ser Arg Asn Lys Val Pro Thr Thr 
225 230 235 240 
Asp Asp Ser His Asn Thr Pro Leu Ser Ser Arg Leu Leu Ser Cys Asp 
245 250 255 
Leu Val Ser Pro Thr Lys Ser Arg Val Lys Ile Tyr Leu Leu Glu Arg 
260 265 270 
Met Val Ser Leu Pro Ala Met Glu Asp Leu Trp Thr Leu Gly Gly Arg 
275 280 285 
Arg Glu Asp Gln Ser Thr Ile Glu Gly Leu Glu Met Ile Arg Glu Leu 
290 295 300 
Trp Gly Leu Leu Asn Met Ser Pro Gly Leu Arg Ala Tyr Pro Glu Pro 
305 310 315 320 
Tyr Leu Pro Leu Gly Ala Ile Pro Asn Glu Gln Leu Pro Ser Met Ala 
325 330 335 
Asn Tyr Thr Leu His His Asn Asp Pro Ile Pro Glu Pro Gln Val Tyr 
340 345 350 
Phe Thr Val Phe Gly Met Asn Asp Met Glu Val Thr Asn Ala Leu Thr 
17 
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355 360 365 
Lys Phe Phe Met Arg His Glu Trp Ser Asp Met Ala Ser Lys Tyr Lys 
370 375 380 
Ala Cys Leu Arg Glu Ser Phe Pro His His Asn Tyr Glu Ala Leu Asn 
385 390 395 400 
Tyr Ile His Ser Tyr Ile Ser Phe Ser Tyr Arg Asn Asn Lys Pro Tyr 
405 410 415 
Leu Ser Val Tyr Leu His Ser Phe Glu Thr Gly Glu Trp Pro Val Phe 
420 425 430 
Pro Glu Gly Leu Ile Ala Phe Asp Gly Cys Arg Arg Asp Leu Thr Cys 
435 440 445 
Tyr Lys 
450 
<2 10> SEQ ID NO 5 
<211> LENGTH: 1908 
<212> TYPE: DNA 
<213> ORGANISM: Neotyphodium coenophialum 
<400> SEQUENCE: 5 
gcattgctac ttcgctaaga agttttcttt taagttgtgt agggatttat tggatgaaac 60 
cttagctagt tggctaataa tcttggaggc taggcagcaa aaccctgatt cttactatgc 120 
tacatgtata atagacttcc tcagatatta atttcaaacc atgtttgcct gttagttctc 180 
tctagcgcaa aggtgacttg ttagaccaca atttgttcaa tctttaactg tatcaaagaa 240 
acagacaggg ctattacgct cgtcctcttc ttcacaatgg taatggcaaa gacactccac 300 
caggaagttt atcataccct tagcgaaaca tttgactttg ccaacaatga ccagaggcta 360 
tggtggcaca gcacggcgcc aatgttcgaa aagatgctcc aaactgctaa ctatagcatt 420 
gatgctcagt atcgacatct gggcatttat aagagccatg tcattccttt tcttggtgtc 480 
tatcctacaa gaagtggcga gcggtggcta agcattctta cgagatacgg aaccccgttt 540 
gagctaagtc ttaattgctc ggactccgta gttcggtata catacgagcc tattaacgcc 600 
gcaactggca gtcatctgga tccgtttaac actttcgcta tctgggaggc cctgaaaaag 660 
catattgagt cccagccagg catagacctt gaatggtttt cttactttaa acaagagctt 720 
acacttgacg caaacgagtc cacgtacctg cactcgcaaa acttggttaa ggaacagatc 780 
aaaactcaaa acaagctcgc tttggacctt aaaggtgaca agttcgtact gaagacctac 840 
atctaccccg aattgaagtc cgtcgcaact ggtaaatcgg tccaggagct cgtgtttggc 900 
tccgtccgca agctagcgca gaagcacaag agtatccgtc ctgcctttga aatgctagaa 960 
gactatgtcc agtctcgcaa taaattctct accacggatg acagtcacaa tactctatta 1020 
tcttcacgcc ttctctcttg cgacctgata agtcctacca agtctcgtgt caagatctac 1080 
ctcctggaac gaatggtctc gttgccagcg atggaagatc tttggacgct tggcggccgt 1140 
cgagaagatc agtccactat tgagggattg gagatgatcc gagaactttg gggtctcctc 1200 
aacatgtctc ctggtttgcg cgcctaccct gagccttact tgcccctcgg cgccattccc 1260 
aatgagcaac ttccgtccat ggccaattac accttacacc ataatgatcc cataccagaa 1320 
ccgcaagtgt actttactgt gttcggcatg aatgatatgg aggtgactaa tgcactcacg 1380 
acattcttca tgaggcatga atggagcgat atggcaagta aatacaaagc ctgcctcagg 1440 
gaatctttgt aagtgatatc ccagctctca cattgcatga caagagttac taacataaaa 1500 
atcgcttggc agcccgcatc atgattacga agccctgaat tatatccact cgtacatttc 1560 
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What is claimed is: 
1. An isolated nucleic acid molecule, Wherein said nucleic 
acid molecule comprises a nucleic acid sequence selected 
from the group consisting of: 
(a) a nucleic acid molecule encoding a dimethylallyltryp 
tophan synthase (DmaW molecule) Which has more 
than 70% identity to a molecule selected from the 
group consisting of SEQ ID NO 1 and SEQ ID NO 3, 
and Wherein said identity can be determined using the 
DNAsis computer program and default parameters; 
(b) a nucleic acid molecule selected from the group 
consisting of: a nucleic acid molecule Which encodes a 
DmaW amino acid molecule selected from the group 
consisting of: SEQ ID NO 2; and SEQ ID NO 4; and 
(c) a nucleic acid molecule fully complementary to a 
nucleic acid molecule selected from the group consist 
ing of: a nucleic acid molecule of (a); and a nucleic acid 
molecule of 
. A knockout construct of a dmaW molecule of claim 1. 
. A vector comprising a knockout construct of claim 2. 
A fungus comprising a knockout construct of claim 2. 
A seed comprising a fungus of claim 4. 
An embryo comprising a fungus of claim 4. 
A plant comprising a fungus of claim 4. 
. A plant of claim 7, Which is a forage grass. 
. A plant of claim 8, Which is a fescue. 
10. A plant of claim 9, Which is a Festuca arundinacea. 
11. A method to express DmaW in a cell, comprising 
transforming a cell With a molecule of claim 1; and incu 
bating said cell under such conditions so as to cause expres 
sion of DmaW. 
12. A method to identify endophytes that contain or lack 
a dmaW gene, comprising contacting a nucleic acid mol 
ecule of claim 1 With DNA of a sample endophyte under 
l><SSC and 0% formamide at about 56° C. hybridiZation 
Wash conditions, and determining if said endophyte contains 
or lacks the dmaW gene based on the results of the hybrid 
iZation reaction. 
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13. A method of claim 12, Wherein said sample endophyte 
is used in commercial plants selected from the group con 
sisting of forage, pasture, turf, land reclamation, and soil 
conservation. 
14. A method for producing increased amount of ergot 
alkaloids, comprising eXpressing the nucleic acid molecule 
according to claim 1 in a host fungal cell, so the copy 
number of messenger RNA derived from transcription of 
said nucleic acid molecule is increased, and alloWing said 
host fungal cell to groW under appropriate groWth 
conditions, Which causes increased production of ergot 
alkaloid. 
15. The isolated nucleic acid molecule according to claim 
1, Wherein said nucleic acid molecule encoding a DmaW 
molecule has more than 75% identity to the nucleic acid 
molecule having the sequence set forth in SEQ ID NO: 1 or 
SEQ ID NO:3. 
16. The isolated nucleic acid molecule according to claim 
1, Wherein said nucleic acid molecule encoding a DmaW 
molecule has more than 80% identity to the nucleic acid 
molecule having the sequence set forth in SEQ ID NO:1 or 
SEQ ID NO:3. 
17. The isolated nucleic acid molecule according to claim 
1, Wherein said nucleic acid molecule encoding a DmaW 
molecule has more than 85% identity to the nucleic acid 
molecule having the sequence set forth in SEQ ID NO:1 or 
SEQ ID NO:3. 
18. The isolated nucleic acid molecule according to claim 
1, Wherein said nucleic acid molecule encoding a DmaW 
molecule has more than 90% identity to the nucleic acid 
molecule having the sequence set forth in SEQ ID NO:1 or 
SEQ ID NO:3. 
19. The isolated nucleic acid molecule according to claim 
1, Wherein said nucleic acid molecule encoding a DmaW 
molecule has more than 95% identity to the nucleic acid 
molecule having the sequence set forth in SEQ ID NO:1 or 
SEQ ID NO:3. 
